Parity as an independent prognostic factor in malignant mixed mesodermal tumors of the endometrium

Gynecologic Oncology

Volumn 64, Issue 1, 1997, Pages 121-125

  Marth, Christian ^b   Windbichler, Gudrun ^c   Petru, Edgar ^c   Dirschlmayer, Walter ^a   Obermair, Andreas ^c   Czerwenka, Klaus ^c   Müller Holzner, Elisabeth ^c   Dapunt, Otto ^c  

^a Hospital of the Barmherzigen Schwestern   (Austria)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CORRELATION FUNCTION; ENDOMETRIUM CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MESODERM; PRIORITY JOURNAL;

EID: 0031013017     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.4538     Document Type: Article

References (13)

1. 1. Fortune, D.W., and Östör, A. G. Mixed Müllerian tumours of the uterus, in Haines and Taylor Obstetrical and Gynaecological Pathology (H. Fox, Ed.), Livingstone, Edinburgh, pp. 457-478 (1987).
2. 2. To, W. W., and Ngan, H. Y. Malignant mixed Müllerian tumors of the uterus, Int. J. Gynaecol. Obstet. 47, 39-44 (1994).
3. 3. Lotocki, R., Rosenheim, N. B., Grumbine, F., Dillon, M., Parmely, T., and Woodruff, J. D. Mixed Müllerian tumors of the uterus: Clinical and pathologic correlation, Int. J. Gyn. Obstet. 20, 237-243 (1982).
4. 4. King, M. E., and Kramer, E. E. Malignant Müllerian mixed tumors of the uterus, Cancer 45, 188-190 (1980).
5. 5. Major, F. J., Blessing, J. A., Siverberg, S. G., Morrow, C. P., Creasman, W. T., Currie, J. L., Yordan, E., and Brady, M. F. Prognostic factors in early-stage uterine sarcoma, Cancer 71, 1702-1709 (1993).
6. 6. Marth, C., Koza, A., Müller-Holzner, E., Fuith, L. C., Hetzel, H., and Dapunt, O. Parity as prognostic factor for malignant mixed Müllerian tumours, Lancet 1, 957 (1989).
7. 7. Hersey, P., Morgan, G., Stone, D. E., McCarthy, W. H., and Milton, G. W. Previous pregnancy as a protective factor against death from melanoma. Lancet 1, 451 (1977).
8. 8. Elwood, J. M., and Coldman, A. J. Previous pregnancy and melanoma prognosis, Lancet 2, 1000-1001 (1978).
9. 9. Begent, R. H. J., and Bagshawe, K. D. The management of high-risk choriocarcinoma, Semin. Oncol. 9, 198-204 (1982).
10. 10. Marth, C., Koza, A., Müller-Holzner, E., Hetzel, H., Fuith, L. C., and Dapunt, O. Prognostisch relevante Faktoren bei Malignomen des Korpus uteri unter besonderer Berücksichtigung des Stadiums, in Incontri di Ostetricia e Ginecologia 1990 (D. Pecorari, U. Tosadori, and H. Gamper, Eds.), CIC Edizioni Internazionali, Rome (1990).
11. 11. George, M., Pejovic, M. H., and Kramar, A. Gynecologic Cooperating Group of French Oncology Centers. Uterine sarcomas: Prognostic factors and treatment modalities - Study on 209 patients, Gyn. Oncol. 24, 58-67 (1986).
12. 12. Hajnal-Papp, R., and Szilágyi, I. Malignant Müllerian tumours of the uterus, Arch. Gynecol. Obstet. 241, 209-219 (1988).
13. 13. Spanos, W. J., Peters, L. J., and Oswald, M. J. Patterns of recurrence in malignant mixed Müllerian tumor of the uterus, Cancer 57, 155-159 (1986).